Literature DB >> 20698576

Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.

Yu Kuang1, Nicolas Salem, David J Corn, Bernadette Erokwu, Haibin Tian, Fangjing Wang, Zhenghong Lee.   

Abstract

Altered choline (Cho) metabolism in cancerous cells can be used as a basis for molecular imaging with PET using radiolabeled Cho. In this study, the metabolism of tracer Cho was investigated in a woodchuck hepatocellular carcinoma (HCC) cell line (WCH17) and in freshly derived rat hepatocytes. The transporter responsible for [(11)C]-Cho uptake in HCC was also characterized in WCH17 cells. The study helped to define the specific mechanisms responsible for radio-Cho uptake seen on the PET images of primary liver cancer such as HCC. Cells were pulsed with [(14)C]-Cho for 5 min and chased for varying durations in cold media to simulate the rapid circulation and clearance of [(11)C]-Cho. Radioactive metabolites were extracted and analyzed by radio-HPLC and radio-TLC. The Cho transporter (ChoT) was characterized in WCH17 cells. WCH17 cells showed higher (14)C uptake than rat primary hepatocytes. [(14)C]-Phosphocholine (PC) was the major metabolite in WCH17. In contrast, the intracellular Cho in primary hepatocytes was found to be oxidized to betaine (partially released into media) and, to a lesser degree, phosphorylated to PC. [(14)C]-Cho uptake by WCH17 cells was found to have both facilitative transport and nonfacilitative diffusion components. The facilitative transport was characterized by Na(+) dependence and low affinity (K(m) = 28.59 ± 6.75 μM) with partial energy dependence. In contrast, ChoT in primary hepatocytes is Na(+) independent and low affinity. Our data suggest that transport and phosphorylation of Cho are responsible for the tracer accumulation during [(11)C]-Cho PET imaging of HCC. WCH17 cells incorporate [(14)C]-Cho preferentially into PC. Conversion of [(14)C]-PC into phosphatidylcholine occurred slowly in vitro. Basal oxidation and phosphorylation activities in surrounding hepatic tissue contribute to the background seen in [(11)C]-Cho PET images.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698576      PMCID: PMC2992798          DOI: 10.1021/mp1001922

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  62 in total

1.  Choline/ethanolamine kinase from rat kidney.

Authors:  K Ishidate; Y Nakazawa
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

2.  Regulation of phosphatidylcholine biosynthesis in Chinese hamster ovary cells by reversible membrane association of CTP: phosphocholine cytidylyltransferase.

Authors:  P S Wright; J N Morand; C Kent
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

3.  Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter.

Authors:  R K Porter; J M Scott; M D Brand
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

4.  Fluoromethylcholine PET in recurrent multifocal hepatoma.

Authors:  N P Lenzo; J Anderson; A Campbell; L Morandeau; T R De Grado
Journal:  Australas Radiol       Date:  2007-12

5.  Control of phosphatidylcholine synthesis in Hep G2 cells. Effect of fatty acids on the activity and immunoreactive content of choline phosphate cytidylyltransferase.

Authors:  P A Weinhold; L Charles; M E Rounsifer; D A Feldman
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

6.  Rodent rhabdomyosarcoma: comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data.

Authors:  Denis Rommel; Anne Bol; Jorge Abarca-Quinones; Frank Peeters; Annie Robert; Daniel Labar; Christine Galant; Vincent Gregoire; Thierry Duprez
Journal:  Mol Imaging Biol       Date:  2009-11-25       Impact factor: 3.488

Review 7.  Studies of human tumors by MRS: a review.

Authors:  W Negendank
Journal:  NMR Biomed       Date:  1992 Sep-Oct       Impact factor: 4.044

8.  In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies.

Authors:  I J Cox; J D Bell; C J Peden; R A Iles; C S Foster; P Watanapa; R C Williamson
Journal:  NMR Biomed       Date:  1992 May-Jun       Impact factor: 4.044

9.  PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.

Authors:  N Salem; Y Kuang; F Wang; G T Maclennan; Z Lee
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-11-28       Impact factor: 2.346

10.  Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.

Authors:  Aditya Bansal; Wang Shuyan; Toshiko Hara; Robert A Harris; Timothy R Degrado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-09       Impact factor: 9.236

View more
  14 in total

1.  L1 cell adhesion molecule signaling is inhibited by ethanol in vivo.

Authors:  Yoav Littner; Ningfeng Tang; Min He; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

2.  In vitro characterization of uptake mechanism of L-[methyl-(3)H]-methionine in hepatocellular carcinoma.

Authors:  Yu Kuang; Fangjing Wang; David J Corn; Haibin Tian; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

Review 3.  Choline metabolism in malignant transformation.

Authors:  Kristine Glunde; Zaver M Bhujwalla; Sabrina M Ronen
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

4.  Choline partially prevents the impact of ethanol on the lipid raft dependent functions of l1 cell adhesion molecule.

Authors:  Ningfeng Tang; Penny Bamford; Jace Jones; Min He; Maureen A Kane; Sandra M Mooney; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

5.  Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Francesco Bertagna; Mattia Bertoli; Giovanni Bosio; Giorgio Biasiotto; Ramin Sadeghi; Raffaele Giubbini; Giorgio Treglia
Journal:  Hepatol Int       Date:  2014-09-03       Impact factor: 6.047

6.  Metabolism of radiolabeled methionine in hepatocellular carcinoma.

Authors:  Yu Kuang; Fangjing Wang; David J Corn; Haibin Tian; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

7.  [18F]-choline PET/CT as an imaging biomarker for primary liver cancers.

Authors:  Zhenghong Lee
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

Review 8.  Functional imaging techniques in hepatocellular carcinoma.

Authors:  V Goh; D Sarker; S Osmany; G J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-21       Impact factor: 10.057

9.  Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line.

Authors:  Silvia Marchese; Angela Sorice; Andrea Ariano; Salvatore Florio; Alfredo Budillon; Susan Costantini; Lorella Severino
Journal:  Toxins (Basel)       Date:  2018-10-28       Impact factor: 4.546

10.  In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism.

Authors:  Kaelan Gobeil Odai; Conor O'Dwyer; Rineke Steenbergen; Tyler A Shaw; Tyler M Renner; Peyman Ghorbani; Mojgan Rezaaifar; Shauna Han; Marc-André Langlois; Angela M Crawley; Rodney S Russell; John P Pezacki; D Lorne Tyrrell; Morgan D Fullerton
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.